E50 (Etoposide 50 mg)

Pill imprint E50 has been identified as Etoposide 50 mg.

Etoposide is used in the treatment of small cell lung cancer; testicular cancer; ovarian cancer; cancer; hodgkin's lymphoma and belongs to the drug class mitotic inhibitors. There is positive evidence of human fetal risk during pregnancy. Etoposide 50 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for E50

Etoposide 50 mg E50
Etoposide 50 mg E50
Etoposide
Imprint:
E50
Strength:
50 mg
Color:
Pink
Size:
23.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Mitotic inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-3266
Inactive Ingredients:
citric acid anhydrous
gelatin
glycerin
hypromellose
ferric oxide red
polyethylene glycol
propylene glycol
water
ferrosoferric oxide
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0965 UDL Laboratories Inc
54868-5355 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)